Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sun Pharma, Cipla Among Systematix's Top Pharma Picks Ahead Of Q1 Results — Full List Inside
Systematix estimates its healthcare coverage universe will post cumulative revenue growth of around 13% YoY.
Airtel to Trent: 44 stocks likely to report double-digit profit slump in Q1. Are your stocks on the list?
Motilal Oswal expects 44 companies, including Bharti Airtel, Trent, IndiGo, HAL, GAIL and Cipla, to report double-digit year-on-year profit declines in the June quarter. Higher energy costs, weaker demand, geopolitical tensions and margin pressure are expected to weigh on earnings, even as overall corporate profit growth slows in Q1.
Buy, Sell Or Hold: HDFC Bank, BEL, Kalyan Jewellers, Ashok Leyland, Cipla And Waaree Energies — Ask Profit
Market experts shared buy, sell and hold recommendations for an array of stocks.
Cipla Ltd soars 2.53%, up for fifth straight session
Cipla Ltd is quoting at Rs 1476.6, up 2.53% on the day as on 12:44 IST on the NSE. The stock is down 1.95% in last one year as compared to a 6.16% drop in NIFTY and a 14.71% drop in the Nifty Pharma.
Nifty Pharma index up 2%; Dr Reddy's, Ajanta, Ipca, Cipla surge up to 5%
In the past seven trading days, the Nifty Pharma index outperformed the market by soaring 5.4 per cent, as compared to 0.1 per cent decline in the Nifty 50.
Cipla Share Price Live Updates: Cipla's Stock Price Movement
Market trading guide: Cipla among 2 stock recommendations for Tuesday
Cipla and Knowledge Marine feature among analysts' top stock picks for Tuesday, backed by bullish technical breakouts, improving momentum indicators and strong chart structures that signal further upside potential.
Top gainers and losers, June 22: Cipla jumps 5%, Tech Mahindra, Dr. Reddy’s up 2%, Titan down 1%; check list - Upstox
Top gainers and losers, June 22: Cipla jumps 5%, Tech Mahindra, Dr. Reddy’s up 2%, Titan down 1%; check listUpstox
Sensex rises 291 points, Nifty tops 24,100: 5 key drivers behind the market rally
Sensex rose 291 to 77094, Nifty gained 90 to 24102, led by HDFC Bank, ICICI Bank, Reliance Industries, Infosys, with IT and pharma stocks like Cipla outperforming
Cipla Share Price Live Updates: Cipla's Stock Breaks Through Resistance Levels
Cipla Share Price Gains 4% As Citi Maintains Bullish Stance For 90-Day Momentum: Check Target Price
Cipla share price gained 4% as Citi held a bullish stance on the stock.
Cipla Share Price: Citi highlights multiple triggers for 90-day positive catalyst watch
Citi believes a series of near-term triggers in the US market could support further upside for the stock. These include the potential approval of generic Flovent (gFlovent), the launch of generic Ventolin (gVentolin), and Cipla's growing presence in the Nintedanib market, where its market share is approaching 50%.